局部晚期头颈部鳞癌治疗进展  

Recent advances in the management of locally advanced head and neck squamous cell carcinoma

作　　者：杨兴龙 李心红[2] Yang Xinglong;Li Xinhong(Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010059,China)

机构地区：[1]内蒙古医科大学附属医院,呼和浩特010059 [2]内蒙古医科大学附属医院放疗科,呼和浩特010059

出　　处：《中华放射肿瘤学杂志》2024年第1期72-78,共7页Chinese Journal of Radiation Oncology

摘　　要：局部晚期头颈部鳞癌目前常规的治疗方案是同步放化疗,但是患者5年生存率仍然不高。近年来放疗技术的发展,为患者提供了更多的选择。而且随着人们生活水平的提高,越来越多的患者更加关注生活质量。目前急需探究更好的综合治疗方案以改善患者的预后。本文就局部晚期头颈部鳞癌的综合治疗进展做一综述。Currently,concurrent chemoradiotherapy is the conventional treatment for locally advanced head and neck squamous cell carcinoma,but the 5-year survival rate of patients is still not high.In recent years,the development of radiotherapy technology has offered more options for patients.In addition,with the improvement of people's living standards,more and more patients begin to pursue the quality of life.There is an urgent need to explore better comprehensive treatment options to improve patient outcomes.In this article,research progress in comprehensive treatment of locally advanced head and neck squamous cell carcinoma was reviewed.

关 键 词：头颈鳞癌 局部晚期 诱导化疗 免疫疗法 凋亡抑制蛋白 放射疗法 

分 类 号：R739.91[医药卫生—肿瘤]